229 related articles for article (PubMed ID: 29727629)
1. Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. l-Dopa/dopamine index as new potential biomarker of renal dysfunction.
Rukavina Mikusic NL; Kouyoumdzian NM; Uceda A; Del Mauro JS; Pandolfo M; Gironacci MM; Puyó AM; Toblli JE; Fernández BE; Choi MR
Metabolism; 2018 Aug; 85():271-285. PubMed ID: 29727629
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic fructose overload on renal dopaminergic system: alteration of urinary L-dopa/dopamine index correlates to hypertension and precedes kidney structural damage.
Rukavina Mikusic NL; Kouyoumdzian NM; Del Mauro JS; Cao G; Trida V; Gironacci MM; Puyó AM; Toblli JE; Fernández BE; Choi MR
J Nutr Biochem; 2018 Jan; 51():47-55. PubMed ID: 29091814
[TBL] [Abstract][Full Text] [Related]
3. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
4. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.
Navarro-Cid J; Maeso R; Perez-Vizcaino F; Cachofeiro V; Ruilope LM; Tamargo J; Lahera V
Hypertension; 1995 Dec; 26(6 Pt 2):1074-8. PubMed ID: 7498971
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
[TBL] [Abstract][Full Text] [Related]
7. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
8. Acute infusion of angiotensin II regulates organic cation transporters function in the kidney: its impact on the renal dopaminergic system and sodium excretion.
Kouyoumdzian NM; Rukavina Mikusic NL; Robbesaul GD; Gorzalczany SB; Carranza A; Trida V; Fernández BE; Choi MR
Hypertens Res; 2021 Mar; 44(3):286-298. PubMed ID: 32934369
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
10. Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats.
Ramos-Filho AC; Moscoso JA; Calmasini F; Faria Jde A; Anhê GF; Mónica FZ; Antunes E
Eur J Pharmacol; 2014 Sep; 738():285-92. PubMed ID: 24881522
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
Iyer SN; Katovich MJ
Am J Hypertens; 1996 Jul; 9(7):662-8. PubMed ID: 8806978
[TBL] [Abstract][Full Text] [Related]
13. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
Garcia R; Bonhomme MC; Diebold S
J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
[TBL] [Abstract][Full Text] [Related]
14. Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats.
Guo Q; Mori T; Jiang Y; Hu C; Ohsaki Y; Yoneki Y; Nakamichi T; Ogawa S; Sato H; Ito S
Hypertens Res; 2012 Jan; 35(1):48-54. PubMed ID: 21900942
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria.
Toblli JE; Ferder L; Stella I; De Cavanaugh EM; Angerosa M; Inserra F
J Urol; 2002 Oct; 168(4 Pt 1):1550-5. PubMed ID: 12352456
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
[TBL] [Abstract][Full Text] [Related]
20. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats.
Hsieh PS
J Hypertens; 2005 Dec; 23(12):2209-17. PubMed ID: 16269963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
